$VOR ripping lately and up 100% since my first entry. B/C it’s one of my #Biopick2025 I’m doing full disc that I take profits for now. Been tough past 6months overall so collecting some while I can. Hope it can continue to run for the contest, IMO nothing changed other than price

Usual pre-market drop in $CRGX on low vol - who’s putting these out for fire sell BDSM style on daily basis? I started to like it at $22 and even more at $15. At $10 I probably hate the stock because it crashed my portfolio but guess I will continue to buy if case is intact.

Just as portfolio started green in 2025 feds finishing it off

Did market really think that Izervay wouldn't be allowed to resubmit? CRL PR sure sounded like a class 1 case $apls

Back in Nov, $LSTA CEO (with abstract in hand) argued that OS and CR rates will be most important. Not sure about it, data set lacks robustness with PFS same as control, but guessing they will try that spin.

$LSTA - if I could go back in time and (re)design the ASCEND trial, I would: 1. Increase sample size and randomize 1:1, as the current 2:1 reduces robustness in an already very small trial. 2. Make OS the primary endpoint, as it has been consistent across 3 trials.

$CRGX